Cargando...
The Role of Hypoxia in Glioblastoma Radiotherapy Resistance
SIMPLE SUMMARY: Glioblastoma (GB) is the deadliest type of primary brain tumor. Following diagnosis the patient´s median survival is only 16 months. There are currently around 450 clinical trials focused on the development of more effective therapies for GB. Nevertheless, radiotherapy remains the mo...
Gardado en:
| Publicado en: | Cancers (Basel) |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7867045/ https://ncbi.nlm.nih.gov/pubmed/33535436 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13030542 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|